Medical Device and Wound Care News and Analysis Blog

OSET 2025: Spotlight on Conmed and BioBrace

Written by Andy Knapik | 11/13/25 11:06 PM

Conmed’s Lisa Donnelly, VP of Marketing for US Orthopedics, and Jeff Ott, Director of R&D, discuss their BioBrace technology in an interview with SmartTRAK at OSET 2025 in Las Vegas. 

Conmed’s Lisa Donnelly, VP of Marketing for US Orthopedics, and Jeff Ott, Director of R&D, sat down with SmartTRAK at the Orthopaedic Summit (OSET) 2025 Annual Meeting in Las Vegas (September 18–25, 2025) to discuss BioBrace and how its bioinductive technology sets it apart from the competition.

To find out more about Conmed and BioBrace, click on the following video (16:30 min). A link to download a complete transcript of the interview is also provided below. 

 

Hey everybody, it's Andy Knapik with SmartTRAK, here at Ortho Summit in Las Vegas, and I'm happy to be here at the ConMed booth, and joined by a good friend of mine, Lisa Donnelly, who's VP of Marketing for US Ortho for ConMed, and then also Jeff Ott, who is a director of R&D. Why don't you just start by talking to us about how you started with the company? I'm just going to let you go with the intro part.

Jeff Ott: 
Yes, happy to do that. I joined a small company called Biorez about six or seven years ago as a small startup. We were focused on trying to find ways to help with tendon and ligament healing, and we developed a product called the BioBrace, which now is a part of ConMed.

So, when was that acquired? That was about a year…

Lisa Donnelly: 
August of 2022.

Okay. So a few years now. Wow. It's flown.

JO: 
Yes, time has flown by. So the BioBrace, which we developed, we designed a product that is a bioinductive scaffold with strength. What we did is we created a product that can both reinforce a tendon or ligament repair, and it also can ...

Want to learn more about the BioBrace technology? Click the button below to download and read the complete transcript of our exclusive interview with Conmed’s Lisa Donnelly, VP of Marketing for US Orthopedics, and Jeff Ott, Director of R&D, conducted by  Andy Knapik, SmartTRAK Sr. Analyst, Soft Tissue & Arthroscopic Technologies.

SmartTRAK is the Medtech industry’s only global Insights-as-a-Service solution for the Orthopedics, Wound Care, Regenerative Medicine and Neuro Therapy markets. SmartTRAK’s proprietary methodology turns disparate data from hundreds of sources into powerful insights customers can rely on as the trusted source for strategic decision-making. The SmartTRAK enterprise platform includes rich daily updates, comprehensive market coverage and simple-to-use tools and dashboards for market, product and financial analysis. Customers leveraging the SmartTRAK platform also have direct access to market experts for inquiries and advisory services. If you would like a demo of what SmartTRAK has to offer and see how we can help increase proficiency, improve productivity and reduce costs for your company, just click here.